Sean D. Sullivan, PhD

Articles by Sean D. Sullivan, PhD

Beyond Survival: Economic Analyses of Chemotherapy in Advanced, Inoperable NSCLC

BySean D. Sullivan, PhD,Trivandrum V. Parasuraman, PhD

February 1st 1998

Research shows that chemotherapy for inoperable non-small-cell lung cancer (NSCLC) improves survival. The economic implications of this treatment choice may be substantial. This paper reviews studies examining the cost-

Latest Updated Articles

Beyond Survival: Economic Analyses of Chemotherapy in Advanced, Inoperable NSCLC
February 1st 1998

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)